CDNA · NASDAQ · STOCK
CareDx, Inc
$47.20
52W $11.27 – $49.76
59/100
$2.44B
21.9
2.42
Is CDNA Bullish or Bearish?
Bullish.
Innellis AI committee rates CareDx, Inc (CDNA) Buy with a composite score of 59/100
, based on 4 analysts with 75% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +16.38 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.62 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 50.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- RSI at 74 is in overbought territory — Technical
- Weekly RSI at 86 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 50.3% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
59/100
Agreement
75%
Analysts
4
Conviction
Contested
Sector Rank
Top 58%
of 192 Healthcare peers
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 74 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 50.3% signals elevated volatility
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
61
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
74.3
Overbought
MACD Histogram
0.395
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.82
Inside Bands
Price vs Moving Averages
EMA 9
$44.79
Above
EMA 21
$40.54
Above
EMA 50
$34.06
Above
EMA 200
$24.33
Above
Fundamental Analysis
Valuation
69
Profitability
50
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
21.9×
P/B Ratio
5.71×
PEG Ratio
-0.02
Dividend Yield
0.00%
52W High
$49.76
52W Low
$11.27
Quality & Growth
ROE
-704.5%
ROA
-516.8%
Gross Margin
7058.2%
Operating Margin
-92.4%
Revenue Growth YoY
—
Debt / Equity
0.05
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 21.9 (inexpensive relative to a 15-40x range); Price-to-book of 5.7x; PEG ratio of -0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -7.0%; Return on assets of -5.2%; Net margin of 24.2%; Gross margin of 70.6%; Current ratio of 4.58 (healthy short-term liquidity); Debt-to-equity of 0.05; Free cash flow per share is positive (1.65); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full CDNA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →